Psychiatry & Behavioral Health
Schizophrenia Clinical Research
Schizophrenia is a complex psychiatric disorder that affects how individuals think, feel, and behave. At CenExel, we partner with sponsors to advance innovative schizophrenia treatments through scientifically driven clinical trials focused on improving long-term patient outcomes and quality of life.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Innovation in Schizophrenia Research
CenExel provides specialized expertise in schizophrenia clinical trials, supporting early-phase through late-phase studies with experienced investigators, advanced recruitment strategies, and diverse patient populations. Our integrated research network helps accelerate treatment development while maintaining the highest standards of patient care and data quality.
Conditions Covered
Schizophrenia Conditions We Research
Our schizophrenia research programs support a wide range of psychiatric and behavioral health conditions across adolescent, adult, and geriatric populations.
- Schizophrenia
- Treatment-Resistant Schizophrenia
- First-Episode Psychosis
- Schizoaffective Disorder
- Bipolar Disorder with Psychotic Features
- Cognitive Impairment in Schizophrenia
- Negative Symptoms of Schizophrenia
- Early-Onset Schizophrenia
Our Approach
Why Sponsors Choose CenExel for Schizophrenia Research
Our schizophrenia research network combines scientific rigor, patient-focused care, and operational excellence to help sponsors accelerate study timelines and improve research outcomes.
01
Advanced Recruitment Strategy
Targeted recruitment campaigns and centralized outreach programs help accelerate patient enrollment across sites.
02
Experienced Psychiatry Investigators
Dedicated psychiatric research specialists with deep experience in schizophrenia and CNS trials.
03
Scalable Multi-Site Operations
Integrated site infrastructure enables consistent data quality and streamlined trial execution nationwide.
04
Comprehensive Patient Support
Patient-centered care models improve retention, compliance, and overall participant experience.
Phase Coverage
Supported Schizophrenia Trial Phases
CenExel supports schizophrenia clinical trials from first-in-human studies through Phase IV post-market research programs.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Schizophrenia Task Force
CenExel’s Schizophrenia Task Force supports sponsors with specialized psychiatric expertise, centralized recruitment strategies, experienced investigators, and scalable research operations across multiple U.S. locations.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
